These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25879875)

  • 1. Loss of AF-6/afadin induces cell invasion, suppresses the formation of glandular structures and might be a predictive marker of resistance to chemotherapy in endometrial cancer.
    Yamamoto T; Mori T; Sawada M; Matsushima H; Ito F; Akiyama M; Kitawaki J
    BMC Cancer; 2015 Apr; 15():275. PubMed ID: 25879875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of AF6/afadin, a marker of poor outcome in breast cancer, induces cell migration, invasiveness and tumor growth.
    Fournier G; Cabaud O; Josselin E; Chaix A; Adélaïde J; Isnardon D; Restouin A; Castellano R; Dubreuil P; Chaffanet M; Birnbaum D; Lopez M
    Oncogene; 2011 Sep; 30(36):3862-74. PubMed ID: 21478912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disrupted interaction between CFTR and AF-6/afadin aggravates malignant phenotypes of colon cancer.
    Sun TT; Wang Y; Cheng H; Xiao HZ; Xiang JJ; Zhang JT; Yu SB; Martin TA; Ye L; Tsang LL; Jiang WG; Xiaohua J; Chan HC
    Biochim Biophys Acta; 2014 Mar; 1843(3):618-28. PubMed ID: 24373847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CLDN6 enhances chemoresistance to ADM via AF-6/ERKs pathway in TNBC cell line MDAMB231.
    Yang M; Li Y; Ruan Y; Lu Y; Lin D; Xie Y; Dong B; Dang Q; Quan C
    Mol Cell Biochem; 2018 Jun; 443(1-2):169-180. PubMed ID: 29159771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of cyclophilin A reverses paclitaxel resistance in human endometrial cancer cells via suppression of MAPK kinase pathways.
    Li Z; Min W; Gou J
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):1001-11. PubMed ID: 24036847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGK1 facilities cisplatin chemoresistance by triggering HSP90/ERK pathway mediated DNA repair and methylation in endometrial endometrioid adenocarcinoma.
    Zhou JW; Tang JJ; Sun W; Wang H
    Mol Med; 2019 Mar; 25(1):11. PubMed ID: 30925862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers.
    Kharma B; Baba T; Mandai M; Matsumura N; Murphy SK; Kang HS; Yamanoi K; Hamanishi J; Yamaguchi K; Yoshioka Y; Konishi I
    Int J Cancer; 2013 Nov; 133(9):2234-44. PubMed ID: 23595697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCC1 gene advances cell invasion ability by regulating ERK signaling pathway in endometrial cancer HEC-1B cell line.
    Shang C; Lu YM; Meng LR
    Int J Gynecol Cancer; 2011 Jul; 21(5):795-9. PubMed ID: 21666489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin activates STAT3 and ERK1/2 pathways and induces endometrial cancer cell proliferation.
    Liu Y; Lv L; Xiao W; Gong C; Yin J; Wang D; Sheng H
    J Huazhong Univ Sci Technolog Med Sci; 2011 Jun; 31(3):365. PubMed ID: 21671179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of ECM-induced dormancy and chemoresistance in A549 human lung carcinoma cells.
    Keeratichamroen S; Lirdprapamongkol K; Svasti J
    Oncol Rep; 2018 Apr; 39(4):1765-1774. PubMed ID: 29436672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of Sam68 expression in endometrial carcinoma.
    Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
    Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
    Yang Z; Liao J; Carter-Cooper BA; Lapidus RG; Cullen KJ; Dan H
    BMC Cancer; 2019 May; 19(1):485. PubMed ID: 31118072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway.
    Guo JL; Tang T; Li JH; Yang YH; Zhang L; Quan Y
    Pathol Oncol Res; 2020 Jul; 26(3):1757-1766. PubMed ID: 31650338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
    Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
    Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BKCa participates in E2 inducing endometrial adenocarcinoma by activating MEK/ERK pathway.
    Wang F; Chen Q; Huang G; Guo X; Li N; Li Y; Li B
    BMC Cancer; 2018 Nov; 18(1):1128. PubMed ID: 30445932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
    Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
    J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer.
    Zhao N; Guo Y; Liu P; Chen Y; Wang Y
    Arch Gynecol Obstet; 2022 Mar; 305(3):693-701. PubMed ID: 34476599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA BANCR Promotes Endometrial Cancer Cell Proliferation and Invasion by Regulating MMP2 and MMP1 via ERK/MAPK Signaling Pathway.
    Wang D; Wang D; Wang N; Long Z; Ren X
    Cell Physiol Biochem; 2016; 40(3-4):644-656. PubMed ID: 27898420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.
    Gentilin E; Minoia M; Bondanelli M; Tagliati F; Degli Uberti EC; Zatelli MC
    Endocrine; 2017 Jun; 56(3):621-632. PubMed ID: 27585662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.